The Honest Company reported Q3 2026 financial results, highlighted by 9.2% organic revenue growth and a record underlying adjusted gross margin of 48.9%. The company also announced a new $30 million share repurchase authorization and raised its full-year 2026 financial outlook.
“Our third quarter results demonstrate what a modern personal care company can deliver when the brand, the portfolio, and the P&L are pointed in the same direction. We achieved over 9% Organic Revenue growth and a record Underlying Adjusted Gross Margin of 49%. As a result of our year-to-date performance and a strong roadmap ahead, we are once again raising our full-year outlook. Given our notable margin progress, we are building on our current investments to continue driving brand scale across baby, big kid, and adult households. With a clear strategic vision, a strong financial foundation, and the continued executional discipline of our Honest team, we believe Honest is well positioned to be the most iconic personal care brand of this generation.”
For the nine months ended September 30, 2026, Power Solutions International reported net sales of $483.2 million, a decrease from $531.2 million in the prior year period, while net income significantly improved to $54.1 million. The company highlighted strategic initiatives including its 'Power Boost 2030' strategy and the acquisition of MTL Manufacturing and Equipment.
Unisys Corporation reported a consolidated net loss of $201.0 million for the third quarter of 2026, an improvement from the $308.9 million loss in the prior year period, despite a slight revenue increase to $471.5 million. The company's financial position shows a total stockholders' deficit of $425.1 million as of September 30, 2026, impacted by significant non-cash pension and postretirement adjustments.
Genpact reported Q3 2026 financial results with total revenue growing 7.3% year-over-year to $1.385 billion, driven by 30.3% growth in its Advanced Technology Solutions segment. The company raised its full-year 2026 guidance for gross margin and adjusted diluted EPS following strong execution in its pivot to 'Agentic Operations'.
Term
Q3 2026
“Q3 was another clear proof point that our pivot to Agentic Operations is working, as our flywheel continues to accelerate. Total revenue grew 7.3% year-over-year, and Advanced Technology Solutions revenue growth increased to 30.3%.”
Balkrishan “BK” Kalra, President and CEO, Genpact
“Our Q3 results reflect the strength of our differentiation and execution, with strong revenue growth, significant year-over-year gross margin expansion, and adjusted diluted EPS growth of 10.3%, and we are raising our full year 2026 gross margin and adjusted diluted EPS guidance to reflect this.”
Prothena reported total revenue of $52.7 million for the first nine months of 2026, driven primarily by $50.1 million from license and intellectual property revenue. The company significantly reduced its operating expenses to $62.6 million compared to $200.1 million in the prior year period, resulting in a narrowed net loss. As of September 30, 2026, the company maintained a cash and cash equivalents balance of $271.4 million.
Citizens, Inc. reported a net income of $1.4 million for the nine months ended September 30, 2026, a decrease from $7.3 million in the prior year period. Total revenues remained relatively stable at $185.2 million, while total stockholders' equity declined to $221.5 million primarily due to unrealized losses on fixed maturity securities.
Alarm.com reported Q3 2026 financial results with total revenue increasing 9% year-over-year to $279.4 million, driven by growth in SaaS and license revenue. The company also raised its full-year 2026 SaaS and license revenue guidance to a range of $756.1 million to $756.3 million.
Workiva Inc. reported total revenue of $262.96 million for the third quarter of 2026, a 17.3% increase from the prior year, driven primarily by subscription and support growth. The company achieved a net income of $19.11 million for the quarter, a significant improvement compared to $2.79 million in the same period of 2025.
Halozyme Therapeutics reported strong growth for the third quarter of 2026, with total revenues increasing to $493.0 million compared to $354.3 million in the prior year, driven primarily by higher royalty and product sales. Net income rose to $247.0 million, while the company significantly restructured its debt through the issuance of 2033 Convertible Notes and the repayment of 2027 and 2028 notes.
Five9 reported Q3 2026 revenue of $323.3 million, up 13% year-over-year, and announced a definitive agreement to acquire Level AI for $325 million in cash. The company also provided full-year 2026 revenue guidance of $1.269 billion to $1.275 billion.
Counterparty
Level AI
“Q3 was another solid quarter, highlighted by accelerating subscription revenue growth, with AI revenue growth stepping up significantly. These results indicate that our Humantic CX strategy is working. As AI reshapes the customer experience landscape, we believe adding Level AI strengthens our competitive position, expands the customers we can serve, and deepens the AI talent behind our continuous innovation.”
CAMP4 Therapeutics reported third quarter 2026 financial results, ending the period with $124.5 million in cash and cash equivalents. The company received regulatory clearances in the UK and EU to expand its Phase 1/2 clinical trial of CMP-002 for SYNGAP1-related disorder and remains on track to dose the first patient by year-end 2026. Management expects its current cash runway to fund operations through the end of 2028.
“The third quarter was one of continued execution for CAMP4. With regulatory clearances now in place in Australia, Argentina, the United Kingdom, and the European Union, we have launched our first-in-human ASCEND Phase 1/2 clinical trial of CMP-002 in patients with SYNGAP1-related disorder.”
Josh Mandel-Brehm, President and Chief Executive Officer
“There are no approved disease-modifying treatments for SYNGAP1, and we are committed to rapidly advancing the development of CMP-002 globally in the hopes of offering SYNGAP1 patients and families a potentially transformative solution that could one day dramatically improve their lives.”
Josh Mandel-Brehm, President and Chief Executive Officer
CVRx reported third quarter 2026 financial results, with total revenue of $13.8 million, a 6% decrease year-over-year. The decline was primarily attributed to lower sales force productivity and challenges with a major payer, though the company expanded its U.S. active implanting centers to 262.
“While we recognize there is more work ahead, we remain encouraged by the progress we are making on key strategic initiatives, including the expansion of Medicare Advantage coverage and the clinical evidence released at HFSA. With new Medicare Advantage coverage policies, BENEFIT-HF enrolling, and continued focus on commercial execution, we are confident in our ability to bring this therapy to more patients living with heart failure.”
Kevin Hykes, President and Chief Executive Officer of CVRx
Astrana Health reported record third-quarter 2026 revenue of $1.02 billion, a 7% increase year-over-year, and record adjusted EBITDA of $77.2 million. Net income attributable to the company rose significantly to $13.0 million, or $0.26 per diluted share, driven by the execution of its AI-native healthcare operating platform.
Term
Q3 2026
“Our third quarter results demonstrate the growing impact of Astrana’s physician-centric, AI-native healthcare operating platform and our team’s continued focus on execution. We delivered record revenue, record adjusted EBITDA, and double-digit organic earnings growth while continuing to invest in the next phase of our growth.”
Brandon Sim, President and Chief Executive Officer
“By combining proprietary technology, aligned physician partnerships, and integrated care delivery, we’re building a scalable, repeatable model to improve patient outcomes and manage the total cost of care – a value proposition that extends across payer and reimbursement models and positions us to create sustainable long-term value for patients, physician partners, and shareholders.”
Brandon Sim, President and Chief Executive Officer
Wolfspeed, Inc. reported a net loss of $143.8 million for the quarter ended September 27, 2026, on revenue of $155.0 million, which declined from $196.8 million in the prior year period. The company emerged from Chapter 11 bankruptcy on September 29, 2025, adopting fresh-start accounting and resulting in a new financial reporting basis for the 'Successor' entity.
Kingsway Corp reported total revenue of $38.9 million for Q3 2026, up from $36.8 million in the prior year period. The company experienced a net loss attributable to common shareholders for the quarter, resulting in basic and diluted loss per share of $0.01. Potentially dilutive securities were excluded from calculations as their inclusion would have been anti-dilutive due to the net loss.
Matrix Service Company reported a return to profitability for the quarter ended September 30, 2026, with net income of $6.2 million compared to a net loss of $3.7 million in the prior year period. Revenue increased slightly to $219.4 million, while operating income improved significantly due to higher gross profits and a reduction in selling, general, and administrative expenses.
AEye reported Q3 2026 revenue of $506 thousand, a 10x increase year-over-year, driven by its expanding customer base which grew to 32 revenue-generating clients. The company recorded its first STRATOS revenue and began recognizing revenue from its multi-million-dollar lunar terrain vehicle agreement with Lunar Outpost.
Term
Q3 2026
“Our success with leveraging our software-defined architecture into new commercial agreements across a wider range of addressable markets is reflected in our accelerating revenue growth. A growing number of customers are choosing AEye for demanding applications that require long-range detection, rugged hardware, and the ability to adapt sensing behavior as their requirements evolve.”
Matt Fisch, CEO of AEye
“We have a growing number of qualified leads entering our pipeline, a record number of customers integrating and validating our software-defined architecture, and we are translating this into a growing number of new commercial engagements. We expect to continue converting our record pipeline into sustained commercial activity, leading to significant revenue growth anticipated in 2027.”
Applied Optoelectronics reported record Q3 2026 revenue of $269.9 million, a significant increase from $118.6 million in the prior year, and returned to GAAP profitability. The company highlighted strong demand for its 800G and 1.6T optical products driven by AI datacenter deployments and announced a multi-year strategic agreement with a Tier 1 hyperscale customer.
Term
Q3 2026
“We are pleased to have generated record revenue for our sixth consecutive quarter and to have returned to GAAP profitability in Q3. We have made meaningful progress in scaling our manufacturing capabilities, particularly for our 800G and 1.6T products, to address demand for AI-related optical technologies that we believe is accelerating.”
Dr. Thompson Lin, AOI’s Founder, President and Chief Executive Officer
“We delivered another solid quarter, including accelerating revenue growth and improving profitability, driven by robust demand and manufacturing expansion in both our datacenter and CATV businesses.”
Dr. Stefan Murry, AOI’s Chief Financial Officer and Chief Strategy Officer
Ingevity Corp reported a net income of $49.3 million for the quarter ended September 30, 2026, compared to $43.5 million in the prior year period. While net sales decreased from $333.1 million to $305.1 million, the company saw a significant recovery in nine-month net income ($144.4 million) compared to a net loss in 2025, largely due to the absence of prior-year goodwill impairment charges.
KLX Energy Services reported Q3 2026 revenue of $186 million, exceeding the high end of its guidance range and representing an 11% sequential increase. The company also highlighted the completion of a backstopped rights offering that converted $87.8 million of debt to equity and raised $37.2 million in new capital, significantly strengthening its balance sheet.
Term
Q3 2026
“Our third quarter results demonstrate the earnings potential of the KLX platform when activity, mix and execution align. Revenue was $186 million, above the high end of our guidance range and up $18 million, or 11%, sequentially, outpacing the 7% increase in the average Lower 48 land rig count.”
Chris Baker, KLX President and Chief Executive Officer
“We made meaningful progress on the three priorities we outlined exiting the second quarter. First, we strengthened our balance sheet through the successful completion of the Backstopped Rights Offering, converting $87.8 million of debt to equity and raising $37.2 million of new equity.”
Chris Baker, KLX President and Chief Executive Officer
Green Plains Inc. reported record third quarter 2026 results with net income of $85.4 million and record adjusted EBITDA of $118.0 million, significantly boosted by $65.4 million in 45Z production tax credit value. The company also announced it executed an agreement on October 29, 2026, to monetize between $250 million and $325 million of its 2026 45Z tax credits.
Term
Q3 2026
“Green Plains delivered record operating performance across the platform in the third quarter, demonstrating the earnings power we’ve built across the business. Following quarter-end, the execution of our 45Z monetization agreement marked another important milestone by providing greater visibility into converting that value into cash. Together, a stronger base business and increased financial flexibility position us to invest in our platform and pursue opportunities where we believe Green Plains can create additional value for shareholders.”
Chris Osowski, President and Chief Executive Officer of Green Plains
“Our strong cash position and free cash flow allow us to explore a variety of options, but our standards for deploying capital have not changed. Every opportunity will be evaluated against risk-adjusted returns, strategic fit, and its ability to create long-term value. We intend to remain disciplined and selective as we determine where the next dollar of capital can generate attractive returns.”
NerdWallet reported revenue of $239.6 million for the third quarter of 2026, a 11% increase year-over-year, with net income of $14.9 million. For the nine months ended September 30, 2026, the company achieved a net income of $39.6 million compared to $34.7 million in the prior year, despite an increase in sales and marketing expenses.
Westrock Coffee reported third quarter 2026 results with net sales of $300.2 million and a net loss of $10.0 million, an improvement from the prior year's $19.1 million loss. The company achieved its sixth consecutive quarter of year-over-year Adjusted EBITDA growth, reaching $26.4 million, and recently completed a $600 million refinancing of its credit facilities.
Term
Q3 2026
“The third quarter was another record quarter for Westrock Coffee, as it was the sixth consecutive quarter of year-over-year Consolidated Adjusted EBITDA growth. We are growing, we are generating cash, and with the recently closed Beverage Solutions credit agreement, we have put the balance sheet on solid footing for the long-term.”
Organogenesis Holdings Inc. reported third quarter 2026 financial results, showing a significant 70% year-over-year revenue decline to $45.5 million. The company posted a net loss of $29.6 million as it navigates what management described as a 'market reset' in the advanced wound care sector. Despite the year-over-year drop, management noted sequential revenue growth and broad-based market share gains across its portfolio.
Term
3 months
“We continue to strengthen our position as a leader in regenerative medicine as customers choose a partner and products they trust. Third quarter revenue increased sequentially, and our market share gains are broad-based across our portfolio. We are defining a sustainable future for advanced wound care as we emerge from the market reset a stronger company anchored by evidence-based living cell products that we believe will be the cornerstone of the market going forward.”
Gary S. Gillheeney, Sr., President, Chief Executive Officer and Chair of the Board
SiriusPoint Ltd. reported net income available to common shareholders of $86.8 million for the third quarter of 2026, consistent with the prior year period. For the nine months ended September 30, 2026, net income rose to $255.0 million from $203.6 million in 2025, driven by higher net earned premiums and improved underwriting results despite a decrease in net investment income.
FIGS, Inc. is an accelerated filer reporting for the period ending September 30, 2026, with 157,487,979 Class A and 8,283,641 Class B shares outstanding. The company highlights risks including macroeconomic pressures, supply chain challenges in the Middle East, and the impact of U.S. Customs and Border Protection orders on Jordanian manufacturing.
Guardian Pharmacy Services reported a significant increase in net income for the nine months ended September 30, 2026, reaching $54.8 million compared to $27.7 million in the prior year period. This growth was driven by improved gross margins and a substantial $11.2 million gain in other income, despite relatively flat year-over-year revenue of $1.06 billion.
CarGurus reported Q3 2026 revenue of $258.4 million, a 12% year-over-year increase, and GAAP net income from continuing operations of $52.8 million. Alongside the results, the company announced that its Board of Directors authorized a new $250.0 million share repurchase program.
“We delivered strong third-quarter results, with revenue up 12% year-over-year at the high end of guidance and Adjusted EBITDA near the high end. We are bringing products to market faster and building from our marketplace foundation into a broader set of AI enabled solutions across the dealer workflow including building out our inventory pillar with the launch of StockVantage.”
Jason Trevisan, Chief Executive Officer of CarGurus
Camp4 Therapeutics Corp is an emerging growth company focused on developing its RAP Platform for research and development programs. As of November 4, 2026, the company had 62,754,200 shares of common stock outstanding and is currently classified as a non-accelerated filer and smaller reporting company.
EDAP TMS (FocalTherics) reported Q3 2026 revenue of $9.8 million, a 26% increase year-over-year, driven by a 32% increase in U.S. procedure volume and seven Focal One system sales. The company narrowed its full-year 2026 revenue guidance to $50.0-$52.0 million, representing 34% to 39% growth over 2025.
Term
Q3 2026
“We demonstrated steady commercial momentum in the third quarter, highlighted by expanding adoption across multiple new regions and additional system sales in the United States, Turkey, Mexico, and France. U.S. procedure volumes accelerated year-over-year to 32% for the third quarter of 2026, compared to 15% in 2025. Driven by our sustained commercial traction, accelerating technology adoption, and our focus on our HIFU opportunity, we remain highly confident in our growth strategy and on the opportunity ahead as we close out the year.”